pharma news today obesity glp-1 Market A diabetes drug. Then a

Selective ferroptosis inhibitor Liproxstatin-1 attenuates neurological deficits and neuroinflammation after subarachnoid hemorrhage

personal factors matter more than the small difference in average outcomes Switching Between Medications Many patients start with one medication and switch to the other

The current study aims to address this gap in knowledge, specifically focusing on a better understanding of placental dysfunction associated with inflammation-driven PE, and subclass-specific therapeutic interventions for this unique patient population

See you at Al Siraj Medical Center

How did your firsthand experience challenge or deepen your understanding of how GLP-1 medications work

Garber AK, Binkley NC, Krueger DC, et al